On August 19, 2026, Johnson Controls International PLC (JCI) shares fell 3.2% to a current price of $144.94. This decline occurs within a 52-week range of $103.

Axxcess Wealth Management LLC bought a new stake in shares of Johnson Controls International plc (NYSE: JCI) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 46,590 shares of the company's stock, valued at approximately $6,807,000. Several other hedge funds also recently

Baker Avenue Asset Management LP lifted its position in shares of Johnson Controls International plc (NYSE: JCI) by 2.7% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 202,420 shares of the company's stock after acquiring an additional 5,284

Atria Investments Inc decreased its stake in Johnson Controls International plc (NYSE: JCI) by 35.6% during the undefined quarter, according to the company in its most recent disclosure with the SEC. The firm owned 17,731 shares of the company's stock after selling 9,790 shares during the period. Atria Investments Inc's holdings in Johnson

Efficiency leaders CLS, ZWS, LRCX, BESIY and JCI outperformed industry peers on key ratios, narrowing a 7,906-stock universe to just 18 picks.

Bank of America Corp DE reduced its position in Johnson Controls International plc (NYSE: JCI) by 7.4% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 17,743,537 shares of the company's stock after selling 1,410,104 shares during the

Johnson Controls International NYSE: JCI reported fiscal third-quarter results marked by double-digit organic sales growth, expanding margins and record backlog, as demand for data-center and other mission-critical thermal-management systems remained strong.

Johnson Controls International plc (JCI) Q3 2026 Earnings Call Transcript

JCI beats third-quarter estimates with double-digit organic growth in key markets and raises its fiscal 2026 outlook on strong operating momentum.

Q3 sales increased 9% and organic sales increased 10%* Q3 GAAP EPS of $1.23; Q3 Adjusted EPS* of $1.42 Q3 orders +27% organically year-over-year Backlog of $21.0 billion increased 32% organically year-over-year *   This earnings release contains non-GAAP financial measures. Definitions and reconciliations of the non-GAAP financial measures can be found in the attached footnotes.